Best for
Mobile

N4 Pharma Plc (N4P) is a leading drug manufacturers-specialty & generic business based in the UK. N4 Pharma is listed on the London Stock Exchange (LSE) and employs 5 staff. All prices are listed in pence sterling.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
52-week range | 2p - 14.5p |
---|---|
50-day moving average | 8.4767p |
200-day moving average | 7.5185p |
Wall St. target price | 12p |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | -1.3p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Revenue TTM | £23,524 |
---|---|
Gross profit TTM | £0 |
Return on assets TTM | -31.18% |
Return on equity TTM | -46.83% |
Profit margin | 0% |
Book value | 0.015p |
Market capitalisation | £14.8 million |
TTM: trailing 12 months
We're not expecting N4 Pharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
N4 Pharma's shares were split on a 200:800 basis on 3 May 2017. So if you had owned 800 shares the day before before the split, the next day you'd have owned 200 shares. This wouldn't directly have changed the overall worth of your N4 Pharma shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for N4 Pharma shares which in turn could have impacted N4 Pharma's share price.
Over the last 12 months, N4 Pharma's shares have ranged in value from as little as 2p up to 14.5p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while N4 Pharma's is 0.0634. This would suggest that N4 Pharma's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel therapeutic products pharmaceutical and biotechnology companies in the United Kingdom. It reformulates marketed generic drugs; and improves delivery of novel and existing vaccines and therapeutics. The company is developing Sildenafil for use in treating erectile dysfunction; Sartans for the treatment of hypertension; Aprepitant for use in oncology and pain relief; and Aprepitant for the treatment of premature ejaculation. It is also developing Nuvec, an engineered silica nanoparticle for use in intracellular delivery of large nucleic acids, such as pDNA and mRNA; and Single dose Hepatitis B vaccine. The company has a research collaboration with MedImmune to explore the manufacture of a prototype nanomedicine using its Nuvec system; and Nanomerics Limited to produce and test two candidate formulations using the Nuvec delivery system. N4 Pharma Plc is based in London, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.